Improving Survivorship Among Minority Cancer Dyads
This proposed intervention centers on improving survivorship outcomes among African American and Latinx cancer survivor and caregiver dyads. As a result, there will be four major outcomes. First, as a result of partnership with minority social institutions (e.g. faith leaders), we will develop an in-depth culturally sensitive curriculum and survivorship care plan for Cancer Survivorship and Caregiver Leaders Aimed for Minority Populations (CSC LAMPs). Second, we will increase knowledge and skills by evaluating a comprehensive cancer survivorship training program designed for underserved health professional students. Third, the implementation of this program will improve survivorship outcomes among African American and Latinx cancer survivors with advanced stage cancer and their caregivers. Lastly, this study will build sustainability for underserved minorities with the training of 30 future healthcare providers as a valuable community resource for improving cancer survivorship outcomes. The long-term outcomes of the CSC LAMPs program will generate workforce capacity and diversity in cancer-based clinical practice, research, and community advocacy for underserved minority cancer survivors and caregivers.
Checked against the public recordLast updated Jul 26, 2022 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Supportive Care
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- Charles Drew University of Medicine and Science
- Interventions being studied
- Behavioral: Change in knowledge, motivation, skills, and resources
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Aim 1 Focus Group for Cancer Survivors and Caregivers: Inclusion Criteria * Individuals ages 18 and older * identify as African American or Latinx * identify as a cancer survivor and/or caregiver * speak and/or understand English Exclusion Criteria * individuals ages 17 years or younger * does not identify as African American or Latinx * unable to speak or understand English * does not identify as a cancer survivor or caregiver Aim 1 Focus Group for Oncology Healthcare Providers: Inclusion Criteria * Individuals ages 18 and older * identify as a healthcare provider * provide care to cancer patients in current provider role * speak and/or understand English Exclusion Criteria * individuals ages 17 years or younger * unable to speak or understand English * does not provide care to cancer patients * does not identify as a healthcare provider Aim 2: Inclusion Criteria * Individuals ages 18 and older * registered as a CDU student * speak and/or understand English * considered to be underserved, which include a) identifying as an underrepresented minority: Asian, Pacific Islander, African American, Hispanic, and Native American/Alaskan Native and/or b) from a medically underserved population (i.e. faced economic, cultural or linguistic barriers to health care) Exclusion Criteria * individuals ages 17 years or younger * not registered as a CDU student * unable to speak or understand English * not considered to be underserved For Aim 3: Inclusion Criteria * cancer survivor with a participating caregiver * stage III or stage IV cancer diagnosis * breast, lung, or colorectal cancer diagnosis * identify as African American or Latinx * speak and/or understand English Exclusion Criteria * individuals ages 17 years or younger * does not identify as African American or Latinx * unable to speak or understand English * does not identify as a cancer survivor * cancer survivor does not identify a caregiver * does not have a breast, lung, or colorectal cancer diagnosis * not diagnosed with a stage III or stage IV cancer diagnosis
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Charles R. Drew University of Medicine & ScienceLos Angeles, California
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jul 26, 2022. Always confirm current availability with the study team.